<\/p>\n
Ezedoc<\/strong> inneh\u00e5ller ezetimibe<\/strong> (10 mg), en kolesterolabsorptionsh\u00e4mmare<\/strong> som blockerar NPC1L1-transport\u00f6ren i tunntarmen. Det \u00e4r go-to add-on therapy when a statin alone doesn\u2019t get LDL to target<\/strong>. On its own, ezetimibe lowers LDL-C by about 17\u201322%. Added to a statin, it produces an additional ~20\u201325% LDL reduction, totaling a 55\u201360% fall \u2014 equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The -studien (18 144 patienter efter akut koronart syndrom) visade att till\u00e4gg av ezetimib till simvastatin ytterligare minskar kardiovaskul\u00e4ra h\u00e4ndelser. Dos: 10 mg en g\u00e5ng dagligen, n\u00e4r som helst, med eller utan mat. Generellt mycket v\u00e4l tolererad \u2014 milda magbesv\u00e4r, sporadisk myalgi, s\u00e4llsynt transaminash\u00f6jning. Undvik vid sv\u00e5r leversvikt.<\/strong> trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10\u00a0mg once daily, any time, with or without food. Generally very well-tolerated \u2014 mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.<\/p>\n<\/div>\n \ud83d\udce6 Varje best\u00e4llning omfattas av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 om din f\u00f6rs\u00e4ndelse inte anl\u00e4nder inom 20 arbetsdagar, skickar vi om den.<\/p>\n V\u00e5ra generiska l\u00e4kemedel kommer fr\u00e5n WHO-GMP-certifierade tillverkare och skickas v\u00e4rlden \u00f6ver i diskret, enkel f\u00f6rpackning \u2014 inget l\u00e4kemedelsnamn p\u00e5 paketets utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdragsbeskrivningar inkluderar en reglerad kortbetalningsprocessor \u2014 aldrig \u201cMedsBase\u201d eller n\u00e5got l\u00e4kemedelsnamn). Krypto och SEPA-bank\u00f6verf\u00f6ring accepteras ocks\u00e5. Varje best\u00e4llning backas upp av v\u00e5r Reshipment Assurance Policy.<\/p>\n Ezedoc \u00e4r ett oralt lipidh\u00e4mmande l\u00e4kemedel som inneh\u00e5ller ezetimibe<\/strong> (10 mg), tillverkad av WHO-GMP-certifierad tillverkare. Levereras i f\u00f6rpackningar om 30, 60, 90 eller 180 tabletter. Ezetimibe \u00e4r den f\u00f6rsta och enda l\u00e4kemedelssubstansen i kolesterolabsorptionsh\u00e4mmare<\/strong> Zetia \/ Ezetrol (Merck, 2002).<\/strong> Ezetimib \u00e4r en grundpelare i andra linjens lipidbehandling \u2014 det f\u00f6rsta valet n\u00e4r mer LDL-s\u00e4nkning beh\u00f6vs \u00e4n vad en tolererad statindos ger, eller n\u00e4r en patient inte tolererar h\u00f6gre statindoser. Det \u00e4r ocks\u00e5 den vanligaste kombinationspartnern i fixkombinationer (simvastatin\/ezetimib = Inegy\/Vytorin; rosuvastatin\/ezetimib = olika).<\/p>\n Ezetimibe is a mainstay of second-line lipid management \u2014 the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin\/ezetimibe = Inegy\/Vytorin; rosuvastatin\/ezetimibe = various).<\/p>\n Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30\u201360%); it is most powerful as an add-on.<\/p>\n Ezetimib h\u00e4mmar selektivt Niemann-Pick C1-Like 1 (NPC1L1)-transport\u00f6r<\/strong> p\u00e5 enterocyter i den proximala tunntarmen. NPC1L1 \u00e4r ansvarig f\u00f6r upptaget av kost- och gallkolesterol fr\u00e5n tarmlumen in i enterocyten.<\/p>\n Med NPC1L1-blockad:<\/p>\n Eftersom ezetimibe och statiner verkar p\u00e5 kompletterande v\u00e4gar<\/strong> (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption\/input. Together they drop LDL more than either can alone, without adding to each other\u2019s side-effect profile.<\/p>\n Utfallsdata: IMPROVE-IT-studien<\/strong> (2015) visade att till\u00e4gg av ezetimib till simvastatin hos patienter efter akut koronart syndrom minskade den sammansatta kardiovaskul\u00e4ra slutpunkten med 6,4 % (NNT 50 \u00f6ver 7 \u00e5r), vilket bekr\u00e4ftar att LDL-s\u00e4nkningen leder till faktisk minskning av h\u00e4ndelser.<\/p>\n Standarddos:<\/strong> 10\u00a0mg once daily at any time of day, with or without food.<\/p>\n Ezetimib \u00e4r ett av de b\u00e4st tolererade lipidh\u00e4mmande l\u00e4kemedlen. Biverkningsprofilen ligger n\u00e4ra placebo i studier.<\/p>\n Vanliga (< 5 %):<\/strong><\/p>\n Ovanliga:<\/strong><\/p>\n Store Ezedoc below 25\u00b0C in a dry place, in the original blister. Keep out of reach of children.<\/p>\n Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% \u2014 much less than a statin (30\u201360%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.<\/p>\n Doubling a statin dose typically adds ~6% LDL reduction (the statin \u201crule of 6\u201d). Adding ezetimibe adds ~20\u201325% LDL reduction. Adding ezetimibe is 3\u20134\u00d7 more effective<\/strong> \u00e4n att dubbla statindosen, och utan den dosrelaterade \u00f6kningen av muskelsymptom. Det \u00e4r d\u00e4rf\u00f6r moderna riktlinjer f\u00f6redrar kombinationen statin + ezetimib framf\u00f6r att h\u00f6ja statindosen till maximal niv\u00e5.<\/p>\n Yes \u2014 the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.<\/p>\n Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent \u2014 pick a time you will remember consistently. Many patients take it at the same time as their statin.<\/p>\n S\u00e4llan. Ezetimib som monoterapi visar biverkningar p\u00e5 muskel p\u00e5 placerboniv\u00e5. N\u00e4r det kombineras med ett statin \u00f6kar det inte meningsfullt statinrelaterade muskelsymptom j\u00e4mf\u00f6rt med statinet ensamt.<\/p>\n Du kan best\u00e4lla Ezedoc (10 mg) fr\u00e5n MedsBase i f\u00f6rpackningar om 30, 60, 90 eller 180 tabletter. Vi skickar v\u00e4rlden \u00f6ver med diskret f\u00f6rpackning och \u00e4kta WHO-GMP-certifierade tillverkares lager.<\/p>\n Ezedoc levereras genom en WHO-GMP-certifierad tillverkare med fullst\u00e4ndig COA-dokumentation. Vi skickar v\u00e4rlden \u00f6ver i enkel, diskret f\u00f6rpackning, och varje best\u00e4llning omfattas av v\u00e5r Reshipment Assurance Policy<\/a>. Your statement descriptor when paying by card shows the regulated payment processor (a regulated card-payment processor), never \u201cMedsBase\u201d or any medication name.<\/p>\n <\/p>\n Andra produkter inom Kroniska tillst\u00e5nd<\/strong> som kunder \u00e4ven tittar p\u00e5:<\/p>\n \u2705 S\u00e4nker kolesterolniv\u00e5erna Ezedoc<\/strong> inneh\u00e5ller Ezetimibe<\/strong>.<\/p>","protected":false},"featured_media":56973,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4210,4211],"class_list":{"0":"post-56972","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-ezedoc","10":"product_tag-ezetimibe","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product\/56972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/comments?post=56972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media\/56973"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media?parent=56972"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_brand?post=56972"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat?post=56972"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_tag?post=56972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Varf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n
Ezedoc \u00e4r ett oralt lipidh\u00e4mmande l\u00e4kemedel inneh\u00e5llande<\/h2>\n
\u2014 som till\u00e4gg till en statin n\u00e4r LDL inte n\u00e5r m\u00e5let vid maximal tolererad statindos<\/h2>\n
\n
Hur fungerar Ezedoc?<\/h2>\n
\n
Dosering och administration<\/h2>\n
\n
Biverkningar<\/h2>\n
\n
\n
L\u00e4kemedelsinteraktioner<\/h2>\n
\n
Vem b\u00f6r inte ta Ezedoc?<\/h2>\n
\n
F\u00f6rvaring<\/h2>\n
Vanliga fr\u00e5gor<\/h2>\n
Kan jag ta Ezedoc ist\u00e4llet f\u00f6r ett statin?<\/h3>\n
Hur j\u00e4mf\u00f6r sig Ezedoc med att dubbla min statindos?<\/h3>\n
Minskar Ezedoc risken f\u00f6r hj\u00e4rtinfarkt och stroke?<\/h3>\n
N\u00e4r ska jag ta Ezedoc?<\/h3>\n
Orsakar Ezedoc muskelv\u00e4rk som statiner?<\/h3>\n
Var kan jag k\u00f6pa Ezedoc online?<\/h3>\n
Relaterade kolesterolmediciner<\/h2>\n
\n
Varf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n
Relaterade alternativ<\/h3>\n
\n
\n\u2705 Minskar Risk f\u00f6r Hj\u00e4rtsjukdom
\n\u2705 F\u00f6rhindrar ateroskleros
\n\u2705 F\u00f6rskrivet av l\u00e4kare
\n\u2705 Alternativ f\u00f6r oral medicinering<\/p>\n